Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michèle Kind

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
European Radiology|July 25, 2018
High-grade soft-tissue sarcoma: optimizing injection improves MRI evaluation of tumor responseAmandine Crombé, François Le Loarer, François Cornelis, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2005
Fludarabine phosphate-CVP in patients over 60 years of age with advanced, low-grade and follicular lymphoma: a dose-finding studyPierre Soubeyran, Alain Monnereau, Houchingue Eghbali, et al.
Radiology|April 10, 2019
Soft-Tissue Sarcomas: Assessment of MRI Features Correlating with Histologic Grade and Patient OutcomeAmandine Crombé, Pierre-Jean Marcellin, Xavier Buy, et al.
Cancer Chemotherapy and Pharmacology|February 26, 2010
"Metronomic" chemotherapy in advanced soft tissue sarcomasAntoine Italiano, Maud Toulmonde, Barbara Lortal, et al.
European Radiology|December 19, 2018
Alveolar soft-part sarcoma: can MRI help discriminating from other soft-tissue tumors? A study of the French sarcoma groupAmandine Crombé, Hervé J Brisse, Pauline Ledoux, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 21, 2018
T<sub>2</sub> -based MRI Delta-radiomics improve response prediction in soft-tissue sarcomas treated by neoadjuvant chemotherapyAmandine Crombé, Cynthia Périer, Michèle Kind, et al.
Academic Radiology|September 22, 2021
Soft Tissue Sarcomas: The Role of Quantitative MRI in Treatment Response EvaluationPaolo Spinnato, Michèle Kind, François Le Loarer, et al.
Brachytherapy|July 25, 2013
Pulsed-dose-rate brachytherapy for uterine cervix carcinoma: 10 years of experience with 226 patients at a single institutionAdeline Petit, Anne Floquet, Olivier Lasbareilles, et al.
JCO Clinical Cancer Informatics|September 15, 2021
Implementing a Machine Learning Strategy to Predict Pathologic Response in Patients With Soft Tissue Sarcomas Treated With Neoadjuvant ChemotherapyAmandine Crombé, Sophie Cousin, Mariella Spalato-Ceruso, et al.
European Radiology|August 27, 2022
Distinct patterns of the natural evolution of soft tissue sarcomas on pre-treatment MRIs captured with delta-radiomics correlate with gene expression profilesAmandine Crombé, Frédéric Bertolo, David Fadli, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
European Radiology|July 25, 2018
High-grade soft-tissue sarcoma: optimizing injection improves MRI evaluation of tumor responseAmandine Crombé, François Le Loarer, François Cornelis, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2005
Fludarabine phosphate-CVP in patients over 60 years of age with advanced, low-grade and follicular lymphoma: a dose-finding studyPierre Soubeyran, Alain Monnereau, Houchingue Eghbali, et al.
Radiology|April 10, 2019
Soft-Tissue Sarcomas: Assessment of MRI Features Correlating with Histologic Grade and Patient OutcomeAmandine Crombé, Pierre-Jean Marcellin, Xavier Buy, et al.
Cancer Chemotherapy and Pharmacology|February 26, 2010
"Metronomic" chemotherapy in advanced soft tissue sarcomasAntoine Italiano, Maud Toulmonde, Barbara Lortal, et al.
European Radiology|December 19, 2018
Alveolar soft-part sarcoma: can MRI help discriminating from other soft-tissue tumors? A study of the French sarcoma groupAmandine Crombé, Hervé J Brisse, Pauline Ledoux, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 21, 2018
T<sub>2</sub> -based MRI Delta-radiomics improve response prediction in soft-tissue sarcomas treated by neoadjuvant chemotherapyAmandine Crombé, Cynthia Périer, Michèle Kind, et al.
Academic Radiology|September 22, 2021
Soft Tissue Sarcomas: The Role of Quantitative MRI in Treatment Response EvaluationPaolo Spinnato, Michèle Kind, François Le Loarer, et al.
Brachytherapy|July 25, 2013
Pulsed-dose-rate brachytherapy for uterine cervix carcinoma: 10 years of experience with 226 patients at a single institutionAdeline Petit, Anne Floquet, Olivier Lasbareilles, et al.
JCO Clinical Cancer Informatics|September 15, 2021
Implementing a Machine Learning Strategy to Predict Pathologic Response in Patients With Soft Tissue Sarcomas Treated With Neoadjuvant ChemotherapyAmandine Crombé, Sophie Cousin, Mariella Spalato-Ceruso, et al.
European Radiology|August 27, 2022
Distinct patterns of the natural evolution of soft tissue sarcomas on pre-treatment MRIs captured with delta-radiomics correlate with gene expression profilesAmandine Crombé, Frédéric Bertolo, David Fadli, et al.
Pageof 7